12 Pharmacy

Founded in 2023, 12 Pharmacy operates out of Tokyo, Japan, focusing on veterinary pharmaceuticals., Beta Venture Capital, and FFG Venture Business Partners. 12 Pharmacy specializes in a diverse range of pharmaceutical products and healthcare services aimed at veterinary care. Its core offerings include prescription medications, over-the-counter drugs, and health supplements designed to address various medical conditions in animals. The company targets retail pharmacies, healthcare professionals, and direct consumers who require effective treatment solutions for animal health. It serves markets across East Asia, Southeast Asia, and select regions in North America, ensuring a broad reach for reliable veterinary pharmaceutical options. Revenue generation for 12 Pharmacy is primarily through direct sales to pharmacies and healthcare providers, as well as online distribution channels. The company engages in bulk purchasing agreements with retailers to maintain a steady flow of products. Partnerships with healthcare institutions promote its flagship products, which are often sold through subscription models for ongoing veterinary care. Pricing strategies include competitive rates for individual units and discounts for larger orders, supporting a sustainable business model that encompasses both B2B and direct-to-consumer markets.

1. Series A

   Apr 20, 2026

   Amount

   Undisclosed

   Investors

   Locked

2. Series A

   Jan 14, 2026

   Amount

   Undisclosed

   Investors

   Locked